DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03861143 (ClinicalTrials.gov)	August 14, 2019	27/2/2019	Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis	A Randomized , Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis	Ulcerative Colitis	Drug: BT-11 (500 mg);Drug: BT-11 (1000 mg);Drug: Placebo	Landos Biopharma Inc.	NULL	Active, not recruiting	18 Years	65 Years	All	198	Phase 2	United States;Bosnia and Herzegovina;Croatia;Poland;Ukraine;Belarus;Georgia;Hungary;Moldova, Republic of;Russian Federation;Serbia

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03861143
(ClinicalTrials.gov)

August 14, 2019

27/2/2019

Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis

A Randomized , Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Drug: BT-11 (500 mg);Drug: BT-11 (1000 mg);Drug: Placebo

Landos Biopharma Inc.

NULL

Active, not recruiting

18 Years

65 Years

All

198

Phase 2

United States;Bosnia and Herzegovina;Croatia;Poland;Ukraine;Belarus;Georgia;Hungary;Moldova, Republic of;Russian Federation;Serbia